Lipopeptides containing an interferon-&ggr; fragment, and uses thereof in pharmaceutical compositions
US6683052B1 · kind B1 · utility
Assignees
Inventors
Key dates
| Filing date | Nov 20, 2000 |
| Grant date | Jan 27, 2004 |
| Priority date | — |
| Expiry date | Nov 20, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns any lipopeptide characterized in that it comprises: a peptide part comprising the peptide sequence consisting of about 30 to about 50 of the last contiguous amino acids of the interferon-&ggr; (IFN-&ggr;) C-terminal end of mammals, whereof, if required, the last 3 to 20 amino acids have been suppressed; and one or several lipophilic parts comprising C4-C20 chain of carbon atoms, saturated or unsaturated, linear or branched, or a steroid group. The invention also concerns any lipopeptide such as defined above containing one or several CD8, and/or CD4, and/or B epitopes. The invention further concerns medicines or vaccines containing any polypeptide such as defined above.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.